Alkem Laboratories Ltd (NSE:ALKEM) Share Price

Company Profile

Business description
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.
Contact
Senapati Bapat Marg
Alkem House, Devashish Building
Lower Parel
MumbaiMH400 013
IND
T: +91 2239829999
https://www.alkemlabs.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
22,833

Recommended

Simplification plan complete, organic growth now the focus.

Nathan Zaia | 20 August 2025

Cost containment and growing revenue bode well for profit margins.

Adrian Atkins | 20 August 2025

Sales growth at CSL was lower than expected but streamlining the business has its perks.

Shane Ponraj, CFA | 19 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,284.20	51.60	0.56%
CAC 40	7,927.61	45.42	-0.57%
DAX 40	24,223.76	53.21	-0.22%
Dow JONES (US)	44,938.31	16.04	0.04%
FTSE 100	9,271.84	16.30	-0.18%
HKSE	25,104.61	61.33	-0.24%
NASDAQ	21,172.86	142.09	-0.67%
Nikkei 225	42,610.17	278.38	-0.65%
NZX 50 Index	13,194.07	122.77	0.94%
S&P 500	6,395.78	15.59	-0.24%
S&P/ASX 200	9,019.10	45.40	0.51%
SSE Composite Index	3,771.10	4.89	0.13%